Preferred Label : ceftolozane sulfate;
CAS number : 7R247U84HY;
Origin ID : M000600991;
UMLS CUI : C3872026;
Manual NTBT mappings (CISMeF)
- Related record
- Semantic type(s)
https://ansm.sante.fr/actualites/lantibiotique-zerbaxa-ceftolozane-tazobactam-nest-plus-disponible-en-raison-dun-arret-temporaire-de-la-production
2020
false
false
false
France
French
pharmacovigilance note
drug contamination
anti-bacterial agents
ceftolozane, tazobactam drug combination
ceftolozane sulfate
Tazobactam Sodium
france
ceftolozane and beta-lactamase inhibitor
ceftolozane
Tazobactam
cephalosporins
penicillanic acid
---
Summary Basis of Decision (SBD) for Zerbaxa
Zerbaxa 1.5 g /vial, ceftolozane (1 g as ceftolozane sulfate) and tazobactam (0.5
g as tazobactam sodium), powder for solution, intravenous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?linkID=SBD00247
2015
false
false
false
false
Canada
French
summary of product characteristics
ceftolozane, tazobactam drug combination
ceftolozane, tazobactam drug combination
ceftolozane
ceftolozane
drug combinations
drug approval
canada
ceftolozane sulfate
ceftolozane sulfate
anti-bacterial agents
anti-bacterial agents
beta-Lactamase Inhibitors
beta-Lactamase Inhibitors
intraabdominal infections
complicated intra-abdominal infections
Complicated infection
urinary tract infections
pyelonephritis
infusions, intravenous
treatment outcome
ceftolozane and beta-lactamase inhibitor
antibiotic therapy
cephalosporins
penicillanic acid
penicillanic acid
cephalosporins
penicillanic acid
Tazobactam
Tazobactam
---
